Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells

Abstract

Recently we identified FUS1 as a candidate tumor suppressor gene (TSG) in the 120 kb 3p21.3 critical region contained in nested lung and breast cancer homozygous deletions. Mutation of FUS1 is infrequent in lung cancers which we have confirmed in 40 other primary lung cancers. In addition, we found no evidence for FUS1 promoter region methylation. Because haploinsufficiency or low expression of Fus1 may play a role in lung tumorigenesis, we tested the effect of exogenously induced overexpression of Fus1 protein and found 60–80% inhibition of colony formation for non-small cell lung cancer lines NCI-H1299 (showing allele loss for FUS1) and NCI-H322 (containing only a mutated FUS1 allele) in vitro. By contrast, a similar level of expression of a tumor-acquired mutant form of FUS1 protein did not significantly suppress colony formation. Also, induced expression of Fus1 under the control of an Ecdysone regulated promoter decreased colony formation 75%, increased the doubling time twofold, and arrested H1299 cells in G1. In conclusion, our data are consistent with the hypothesis that FUS1 may function as a 3p21.3 TSG, warranting further studies of its function in the pathogenesis of human cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Abbreviations

TSG:

tumor suppressor gene

SCLC:

small cell lung cancer

NSCLC:

non-small cell lung cancer

LOH:

loss of heterozygosity

SSCP:

single strand conformation polymorphism analysis

FACS:

fluorescence activated cell sorter

References

  • Burbee D, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar A, Lerman M, Zabarovsky E, White M, Minna J . 2001 J. Natl. Cancer Inst. 93: 691–699

  • Clark SJ, Harrison J, Paul CL, Frommer M . 1994 Nucleic. Acids. Res. 22: 2990–2997

  • Cook WD, McCaw BJ . 2000 Oncogene 19: 3434–3438

  • Daly MC, Xiang RH, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD, Naylor SL . 1993 Oncogene 8: 1721–1729

  • Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP . 2000 Nat. Genet. 25: 315–319

  • Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP . 1998 Nat. Genet. 19: 348–355

  • Forgacs E, Biesterveld EJ, Sekido Y, Fong K, Muneer S, Wistuba II, Milchgrub S, Brezinschek R, Virmani A, Gazdar AF, Minna JD . 1998 Oncogene 17: 1557–1565

  • Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y, Takahashi T . 1992 Oncogene 7: 445–449

  • Killary AM, Wolf ME, Giambernardi TA, Naylor SL . 1992 Proc. Natl. Acad. Sci. USA 89: 10877–10881

  • Kok K, Naylor SL, Buys CH . 1997 Adv. Cancer Res. 71: 27–92

  • Kok K, Osinga J, Carritt B, Davis M, van der Hout A, van der Veen A, Landsvater R, de Leij L, Berendsen H, Postmus P, Poppema S, Buys C . 1987 Nature (London) 330: 578–581

  • Kok K, van den Berg A, Veldhuis P, van der Veen A, Franke M, Schoenmakers E, Hulsbeek M, van der Hout A, de Leij L, van de Ven W, Buys C . 1994 Cancer Res. 54: 4183–4187

  • Lerman M, Minna J . 2000 Cancer Res. 60: 6116–6133

  • Naylor SL, Johnson BE, Minna JD, Sakaguchi AY . 1987 Nature 329: 451–454

  • Roche J, Boldog F, Robinson M, Robinson L, Varella-Garcia M, Swanton M, Waggoner B, Fishel R, Franklin W, Gemmill R, Drabkin H . 1996 Oncogene 12: 1289–1297

  • Sekido Y, Ahmadian M, Wistuba II, Latif F, Bader S, Wei MH, Duh FM, Gazdar AF, Lerman MI, Minna JD . 1998 Oncogene 16: 3151–3157

  • Wei MH, Latif F, Bader S, Kashuba V, Chen JY, Duh FM, Sekido Y, Lee CC, Geil L, Kuzmin I, Zabarovsky E, Klein G, Zbar B, Minna JD, Lerman MI . 1996 Cancer Res. 56: 1487–1492

  • Whang-Peng J, Bunn PJ, Kao SC, Lee EC, Carney DN, Gazdar A, Minna JD . 1982 Cancer Genet. Cytogenet. 6: 119–134

  • Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW 3rd, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD . 2000 Cancer Res. 60: 1949–1960

  • Xu X, Brodie SG, Yang X, Im YH, Parks WT, Chen L, Zhou YX, Weinstein M, Kim SJ, Deng CX . 2000 Oncogene 19: 1868–1874

  • Zöchbauer-Müller S, Fong K, Virmani A, Geradts J, Gazdar A, Minna J . 2001 Cancer Res. 61: 249–255

Download references

Acknowledgements

This work was supported by NCI grants CA71618 and Lung Cancer SPORE P50 CA70907, and the G Harold and Leila Y Mathers Charitable Foundation. V Kashuba and E Zabarovsky were funded by grants from the Swedish Cancer Society, Karolinska Institute and the Royal Swedish Academy of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John D Minna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kondo, M., Ji, L., Kamibayashi, C. et al. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene 20, 6258–6262 (2001). https://doi.org/10.1038/sj.onc.1204832

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204832

Keywords

This article is cited by

Search

Quick links